HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 120 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $29,992,000 | -17.4% | 3,035,630 | +1.0% | 0.00% | -33.3% |
Q3 2016 | $36,301,000 | +47.8% | 3,005,011 | +5.6% | 0.01% | +50.0% |
Q2 2016 | $24,555,000 | -9.0% | 2,845,357 | -0.2% | 0.00% | 0.0% |
Q1 2016 | $26,992,000 | -45.9% | 2,850,270 | -1.0% | 0.00% | -50.0% |
Q4 2015 | $49,887,000 | +36.7% | 2,878,642 | +5.9% | 0.01% | +33.3% |
Q3 2015 | $36,497,000 | -41.5% | 2,717,579 | -1.7% | 0.01% | -40.0% |
Q2 2015 | $62,438,000 | +50.4% | 2,765,185 | -4.9% | 0.01% | +66.7% |
Q1 2015 | $41,525,000 | +47.7% | 2,907,935 | -0.2% | 0.01% | +50.0% |
Q4 2014 | $28,105,000 | +6.3% | 2,912,435 | +0.3% | 0.00% | 0.0% |
Q3 2014 | $26,428,000 | -8.1% | 2,904,204 | -0.2% | 0.00% | -20.0% |
Q2 2014 | $28,746,000 | -19.9% | 2,909,476 | +3.1% | 0.01% | -16.7% |
Q1 2014 | $35,867,000 | -5.4% | 2,823,050 | +11.6% | 0.01% | -14.3% |
Q4 2013 | $37,915,000 | +34.3% | 2,529,358 | -1.1% | 0.01% | +40.0% |
Q3 2013 | $28,225,000 | +41.7% | 2,556,584 | +2.0% | 0.01% | +25.0% |
Q2 2013 | $19,919,000 | – | 2,505,503 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 1,129,551 | $51,293,000 | 7.24% |
First Light Asset Management, LLC | 2,050,273 | $93,103,000 | 5.59% |
TRAN CAPITAL MANAGEMENT, L.P. | 1,350,870 | $61,343,000 | 5.06% |
SNYDER CAPITAL MANAGEMENT L P | 3,176,404 | $144,241,000 | 4.04% |
DOHENY ASSET MANAGEMENT /CA | 91,930 | $4,175,000 | 2.69% |
Redwood Investments, LLC | 538,656 | $24,460,000 | 1.97% |
HighMark Wealth Management LLC | 53,457 | $2,427,000 | 1.78% |
Taylor Wealth Management Partners | 85,409 | $3,878,000 | 1.37% |
SILVERARC CAPITAL MANAGEMENT, LLC | 66,673 | $3,028,000 | 1.35% |
Granite Investment Partners, LLC | 919,029 | $41,733,000 | 1.29% |